Earnings Summary

Dr. Reddy's Laboratories Ltd.’s revenue jumped 15.82% since last year same period to $62968Mn in the Q1 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -6.99% fall in its revenue since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit jumped 996.23% since last year same period to $9592Mn in the Q1 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -23.09% fall in its net profits since last 3-months.

Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 846.51% since last year same period to 15.23% in the Q1 2023. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -17.31% fall in its net profit margins since last 3-months.

Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q1 2023 earnings stands at 16.45.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 0.71 - a 7.07% jump from last quarter’s estimates.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 0.71.

Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2023. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.